Assessment of novel diffusion MRI metrics of cortical microstructure in the genetic continuum of Parkinson’s disease
Objective: To investigate novel cortical diffusivity metrics in Parkinson’s disease (PD), including both prodromal and established genetic PD, alongside sporadic PD and healthy controls (HC).…Identifying meaningful symptoms and impacts of disease for patients with early Parkinson’s disease
Objective: To explore meaningful symptoms and impacts of disease on daily living in individuals with early-stage Parkinson’s disease (PD). Background: Critical Path for Parkinson’s (CPP)…Gut dysbiosis in patients with dementia with Lewy bodies
Objective: To identify intestinal bacteria that are changed in DLB alone or in both DLB and cognitive decline in Parkinson’s disease (PD). Background: Gut microbiota…Cortical oscillatory feature-based classification of Parkinson’s disease with freezing gait
Objective: The objective of this study was to determine the resting-state cortical oscillations and the machine learning model that best classifies Parkinson’s disease (PD) patients…Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease
Objective: To evaluate the feasibility of telemedicine among PD patients in Nepal. Background: Nepal is a mountainous country occupying about 85% by Himalayas and hills…Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression
Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is a common neuropsychiatric feature of Parkinson’s…Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy
Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…Characterising Natural Killer cells in early Parkinson’s disease
Objective: To determine whether the number and phenotype of Natural Killer (NK) cells in the blood is altered in early Parkinson’s disease (PD). Background: Accumulating…Intermediate cardiac denervation in early Parkinson’s disease
Objective: This study is aimed to evaluate the longitudinal associations between cardiac sympathetic denervation and cognitive status in Parkinson’s disease (PD). Background: There lacks an…Multi-modal prognostic biomarkers for Parkinson’s disease progression and severity
Objective: To determine a pathophysiological panel of biomarkers significantly associated with the severity and the disease progression of Parkinson’s disease. Background: Detecting, monitoring and predicting…
- « Previous Page
- 1
- …
- 265
- 266
- 267
- 268
- 269
- …
- 338
- Next Page »